Mural Oncology (MURA) Institutional Ownership $1.68 -0.10 (-5.62%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$1.65 -0.03 (-1.85%) As of 08/7/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Mural Oncology (NASDAQ:MURA)CurrentInstitutional OwnershipPercentage80.21%Number ofInstitutional Buyers(last 12 months)23TotalInstitutional Inflows(last 12 months)$13.52MNumber ofInstitutional Sellers(last 12 months)16TotalInstitutional Outflows(last 12 months)$3.16M Get MURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Mural Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MURA Institutional Buying and Selling by Quarter Mural Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/4/2025 Emerald Mutual Fund Advisers Trust77,567$192K0.0%N/A0.449% 6/27/2025Goldman Sachs Group Inc.109,922$139K0.0%-5.1%0.636% 5/19/2025Acorn Capital Advisors LLC1,269,715$1.60M1.0%-1.3%7.353% 5/16/2025Goldman Sachs Group Inc.109,922$139K0.0%-5.1%0.637% 5/15/2025Armistice Capital LLC1,722,000$2.17M0.0%+1.3%9.972% 5/15/2025Solas Capital Management LLC887,995$1.12M0.6%-30.0%5.142% 4/29/2025 Concurrent Investment Advisors LLC22,500$28K0.0%N/A0.131% 2/18/2025Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/17/2025Squarepoint Ops LLC175,502$565K0.0%+1.4%1.031% 2/17/2025Two Sigma Advisers LP26,000$84K0.0%N/A0.153% Get the Latest News and Ratings for MURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Two Sigma Investments LP65,150$210K0.0%+12.0%0.383% 2/17/2025Prosight Management LP466,822$1.50M0.4%-18.2%2.743% 2/17/2025Millennium Management LLC168,255$542K0.0%-11.1%0.989% 2/17/2025Bridgeway Capital Management LLC29,300$94K0.0%N/A0.172% 2/17/2025Acorn Capital Advisors LLC1,286,079$4.14M2.3%N/A7.556% 2/14/2025Jane Street Group LLC21,117$68K0.0%N/A0.124% 2/14/2025Northern Trust Corp39,966$129K0.0%+22.0%0.235% 2/14/2025RBF Capital LLC338,669$1.09M0.1%-5.9%1.990% 2/14/2025Price T Rowe Associates Inc. MD26,905$87K0.0%-28.6%0.158% 2/14/2025Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/13/2025Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 2/13/2025Renaissance Technologies LLC238,465$768K0.0%+17.4%1.401% 2/12/2025Geode Capital Management LLC181,029$583K0.0%-4.7%1.064% 2/12/2025Nicollet Investment Management Inc.94,737$305K0.1%-4.3%0.557% 2/11/2025Virtu Financial LLC40,025$129K0.0%N/A0.235% 2/6/2025Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 1/13/2025 FNY Investment Advisers LLC15,000$48K0.0%-25.0%0.088% 11/16/2024Geode Capital Management LLC190,056$595K0.0%+2.6%1.115% 11/15/2024RBF Capital LLC359,900$1.13M0.1%-7.3%2.112% 11/15/2024Point72 Asset Management L.P.108,715$340K0.0%N/A0.638% 11/15/2024Centiva Capital LP203,706$638K0.0%-9.3%1.195% 11/15/2024Point72 Asia Singapore Pte. Ltd.12,574$39K0.0%-52.8%0.074% 11/14/2024Verition Fund Management LLC340,000$1.06M0.0%-33.4%1.996% 11/13/2024BNP Paribas Financial Markets28,048$88K0.0%-71.0%0.165% 11/13/2024FMR LLC20,580$64K0.0%+124.7%0.121% 11/9/2024Primecap Management Co. CA140,045$438K0.0%-40.5%0.822% 11/8/2024Commerce Bank12,423$39K0.0%N/A0.073% 9/16/2024Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 9/16/2024Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/15/2024Armistice Capital LLC1,688,000$5.30M0.1%N/A9.974% Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again.8/15/2024Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/14/2024Squarepoint Ops LLC167,644$526K0.0%N/A0.991% 8/14/2024Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 8/13/2024Canada Pension Plan Investment Board22,360$70K0.0%N/A0.132% 8/9/2024Primecap Management Co. CA235,551$740K0.0%N/A1.392% 8/9/2024Renaissance Technologies LLC232,100$729K0.0%N/A1.371% 8/9/2024Dimensional Fund Advisors LP22,563$71K0.0%N/A0.133% 8/8/2024Nicollet Investment Management Inc.98,016$308K0.1%N/A0.579% 8/6/2024Acadian Asset Management LLC318,536$998K0.0%N/A1.882% 8/5/2024BBR Partners LLC10,000$31K0.0%N/A0.059% 8/1/2024Rhumbline Advisers10,786$34K0.0%N/A0.064% 7/9/2024 Harbor Capital Advisors Inc.36,769$115K0.0%N/A0.217% (Data available from 1/1/2016 forward) MURA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MURA shares? During the previous two years, 38 institutional investors and hedge funds held shares of Mural Oncology. The most heavily invested institutionals were Armistice Capital LLC ($2.17M), Acorn Capital Advisors LLC ($1.60M), Prosight Management LP ($1.50M), Solas Capital Management LLC ($1.12M), RBF Capital LLC ($1.09M), Verition Fund Management LLC ($1.06M), and Acadian Asset Management LLC ($998K).Learn more on Mural Oncology's institutional investors. What percentage of Mural Oncology's stock is owned by institutional investors? 80.21% of Mural Oncology's stock is owned by institutional investors. Learn more on MURA's institutional investor holdings. Which institutional investors have been buying Mural Oncology's stock? Of the 27 institutional investors that purchased Mural Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.71M), Acorn Capital Advisors LLC ($1.29M), Acadian Asset Management LLC ($318.54K), Renaissance Technologies LLC ($267.50K), Primecap Management Co. CA ($235.55K), Squarepoint Ops LLC ($170.11K), and Raymond James Financial Inc. ($112.35K). How much institutional buying is happening at Mural Oncology? Institutional investors have bought a total of 4,310,283 shares in the last 24 months. This purchase volume represents approximately $13.52M in transactions. Which of Mural Oncology's major shareholders have been selling company stock? Of the 16 institutional investors that sold Mural Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Solas Capital Management LLC ($381.01K), Alpine Global Management LLC ($259.25K), Verition Fund Management LLC ($170.85K), Prosight Management LP ($103.80K), Primecap Management Co. CA ($95.51K), BNP Paribas Financial Markets ($68.69K), and RBF Capital LLC ($49.47K). How much institutional selling is happening at Mural Oncology? Institutional investors have sold a total of 1,241,619 shares in the last 24 months. This volume of shares sold represents approximately $3.16M in transactions. Related Companies Lifevantage Institutional Ownership BioAge Labs Institutional Ownership C4 Therapeutics Institutional Ownership Nuvectis Pharma Institutional Ownership Puma Biotechnology Institutional Ownership Black Diamond Therapeutics Institutional Ownership Cellectis Institutional Ownership Alpha Cognition Institutional Ownership Molecular Partners Institutional Ownership Greenwich LifeSciences Institutional Ownership This page (NASDAQ:MURA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
